[PLX] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
14-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -226.35%
YoY- -61.60%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 10,486 8,617 8,549 19,495 17,759 27,018 2,469 27.24%
PBT -6,426 -3,210 -6,667 397 291 9,781 -15,141 -13.30%
Tax -382 530 908 -212 180 99 916 -
NP -6,044 -3,740 -6,667 397 291 9,781 -15,141 -14.18%
Tax Rate - - - 53.40% -61.86% -1.01% - -
Total Cost 16,530 12,357 15,216 19,098 17,468 17,237 17,610 -1.04%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -57.64 -43.40 -77.99 2.04 1.64 36.20 -613.24 -32.55%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.08 -0.07 -0.15 0.01 0.02 0.66 -1.08 -35.18%
EPS Diluted -0.08 -0.07 -0.15 0.01 0.02 0.66 -1.04 -34.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.